Skip to main content

Tweets

This week’s RheumNow Live pre-Learn spotlight: Vasculitis & Autoimmune disease. We’re diving into this important topic with expert-led talks from Drs. Nancy Olsen, Matthew Baker, and Clay Cockerell. To help you get the most out of their sessions, our speakers have shared key https://t.co/zLKY52Fi17
Dr. John Cush @RheumNow ( View Tweet )
1 month 1 week ago

Medicare Primary Care Shortage - betw 2013 -2021, PCPs decr 25%, while APPs rose 91%. 2021 AVAILABILITY per 10,000 Medicare beneficiaries; - Total clinicians: 23.4 to 22.2 (–5%) - Total new visits: 1162 to 1102 (–5%) - Total PCPs: 20.0 to 15.5 (–22%) - APPs: 3.4 to 6.7 (+97%) https://t.co/ALQI3O3Ian

Dr. John Cush @RheumNow ( View Tweet )
1 month 1 week ago
Emergency Department Visits by Rheumatoid Patients A Canadian population study shows that rheumatoid arthritis (RA) patients have 30% higher emergency department (ED) visit rates for Ambulatory Care Sensitive Conditions (ACSCs) compared to age- and sex-matched population https://t.co/BL8AkXhkFG
Dr. John Cush @RheumNow ( View Tweet )
1 month 1 week ago
Smartphones and Rheumatoid Flares FORWARD Databank of Rheumatoid arthritis (RA) patients reveals that smartphone data can predict flares using PROs. https://t.co/xy6uqsQNt2 https://t.co/JwZlOLco6V
Dr. John Cush @RheumNow ( View Tweet )
1 month 1 week ago
Rheum Survey> 40 yoF RA pt on Prednisone 5 mg/d is at increased risk for ?

Dr. John Cush @RheumNow ( View Tweet )

1 month 1 week ago
What Is Restless Legs Syndrome? JAMA Patient Education handout. https://t.co/fCqArVxrSu https://t.co/xjl0PTdgsu
Dr. John Cush @RheumNow ( View Tweet )
1 month 1 week ago
Nurse Practitioner Independence A JAMA Viewpoint article reports on a March 2025 Nurse Practitioner (NP) Entrepreneurship Summit in Boston in March 2025 identifying barriers and opportunities to NP-owned medical practices. https://t.co/rkzLwhnNYh https://t.co/bxJWptPQK9
Dr. John Cush @RheumNow ( View Tweet )
1 month 1 week ago

2024 Cardiology Income Survey - CV APP salary has incr 15% from 2019 -23, median=$123K - 50% of APP programs lead by an APP >90% work in outpt. clinics - 2/3 of prgs deploy APPs lipid & prevention management - 2 APPs for every 3 cardiologists https://t.co/gtdm5qN1qD https://t.co/cx2JUcw4U3

Dr. John Cush @RheumNow ( View Tweet )
1 month 1 week ago
German psoriasis registry PsoBest reports on 595 Rx w/ apremilast (417 APR monotherapy). Compared to Ptx Rx w/ other DMARDs/biologic drugs, APR pts higher age, more comorbidities. Nonserious AEs: ineffectiveness (14%), diarrhea (9%), nausea (7%), HA (6%). https://t.co/TviJmM7Fr9 https://t.co/tY89oHgUgV
Dr. John Cush @RheumNow ( View Tweet )
1 month 1 week ago
Evaluation of pts w/ muscle weakness and elevated muscle enzymes https://t.co/1Yn3OXXEH6 https://t.co/qsTr4U1xV7
Dr. John Cush @RheumNow ( View Tweet )
1 month 1 week ago
Diffuse Alveolar Hemorrhage in Rheumatic Disease A retrospective, cross-sectional, single-center study of adult rheumatic disease patients with diffuse alveolar hemorrhage (DAH), demonstrates a high proportion have coexistent pulmonary infection and significant mortality risk. https://t.co/K1fLo5iHpd
Dr. John Cush @RheumNow ( View Tweet )
1 month 1 week ago
Drugs that may cause toxic myopathy, presenting as muscle dysfunction w/ weakness and elevated muscle enzymes and possibly confused w/ idiopathic inflammatory myopathies (IIM) - full read review of mimickers of myositis. https://t.co/3wdLvkxcAX https://t.co/OqLjv45HXH
Dr. John Cush @RheumNow ( View Tweet )
1 month 1 week ago
×